28296680|t|Primitive Neuroectodermal Tumors of the Female Genital Tract: A Morphologic, Immunohistochemical, and Molecular Study of 19 Cases
28296680|a|Primary primitive neuroectodermal tumor (PNET) of the female genital tract is rare, and its proper classification remains unclear. The clinical, histologic, and immunophenotypic features as well as EWSR1 rearrangement status of 19 gynecologic PNETs, including 10 ovarian, 8 uterine, and 1 vulvar tumors, are herein reported. Patient age ranged from 12 to 68 years, with a median age of 20 and 51 years among those with ovarian and uterine PNETs, respectively. Morphologic features of central nervous system (CNS) tumors were seen in 15 PNETs, including 9 medulloblastomas, 3 ependymomas, 2 medulloepitheliomas, and 1 glioblastoma, consistent with central PNET. The remaining 4 PNETs were composed entirely of undifferentiated small round blue cells and were classified as Ewing sarcoma/peripheral PNET. Eight PNETs were associated with another tumor type, including 5 ovarian mature cystic teratomas, 2 endometrial low-grade endometrioid carcinomas, and a uterine carcinosarcoma. By immunohistochemistry, 17 PNETs expressed at least 1 marker of neuronal differentiation, including synaptophysin, NSE, CD56, S100, and chromogranin in 10, 8, 14, 8, and 1 tumors, respectively. GFAP was positive in 4 PNETs, all of which were of central type. Membranous CD99 and nuclear Fli-1 staining was seen in 10 and 16 tumors, respectively, and concurrent expression of both markers was seen in both central and Ewing sarcoma/peripheral PNET s. All tumors expressed vimentin, whereas keratin cocktail (CAM5.2, AE1/AE3) staining was only focally present in 4 PNETs. Fluorescence in situ hybridization was successful in all cases and confirmed EWSR1 rearrangement in 2 of 4 tumors demonstrating morphologic features of Ewing sarcoma/peripheral PNET and concurrent CD99 and Fli-1 expression. In conclusion, central and Ewing sarcoma/peripheral PNETs may be encountered in the female genital tract with central PNETs being more common. Central PNETs show a spectrum of morphologic features that overlaps with CNS tumors but lack EWSR1 rearrangement s. GFAP expression supports a morphologic impression of central PNET and is absent in Ewing sarcoma/peripheral PNET. Ewing sarcoma/peripheral PNETs lack morphologic features of CNS tumors.
28296680	0	32	Primitive Neuroectodermal Tumors	T038	UMLS:C0206663
28296680	40	60	Female Genital Tract	T017	UMLS:C0017421
28296680	112	117	Study	T062	UMLS:C2603343
28296680	130	169	Primary primitive neuroectodermal tumor	T038	UMLS:C0206663
28296680	171	175	PNET	T038	UMLS:C0206663
28296680	184	204	female genital tract	T017	UMLS:C0017421
28296680	229	243	classification	T170	UMLS:C0008902
28296680	291	307	immunophenotypic	T058	UMLS:C0079611
28296680	328	333	EWSR1	T017	UMLS:C0808901
28296680	334	347	rearrangement	T038	UMLS:C0017287
28296680	361	372	gynecologic	T082	UMLS:C0205480
28296680	373	378	PNETs	T038	UMLS:C0206663
28296680	393	400	ovarian	T017	UMLS:C0205065
28296680	404	411	uterine	T017	UMLS:C0042149
28296680	419	425	vulvar	T017	UMLS:C0042993
28296680	426	432	tumors	T038	UMLS:C0027651
28296680	445	453	reported	T170	UMLS:C0684224
28296680	549	556	ovarian	T017	UMLS:C0205065
28296680	561	568	uterine	T017	UMLS:C0042149
28296680	569	574	PNETs	T038	UMLS:C0206663
28296680	614	636	central nervous system	T022	UMLS:C3714787
28296680	638	641	CNS	T022	UMLS:C3714787
28296680	643	649	tumors	T038	UMLS:C0027651
28296680	666	671	PNETs	T038	UMLS:C0206663
28296680	685	701	medulloblastomas	T038	UMLS:C0025149
28296680	705	716	ependymomas	T038	UMLS:C0014474
28296680	720	739	medulloepitheliomas	T038	UMLS:C0334596
28296680	747	759	glioblastoma	T038	UMLS:C0017636
28296680	777	789	central PNET	T038	UMLS:C0206663
28296680	807	812	PNETs	T038	UMLS:C0206663
28296680	856	878	small round blue cells	T017	UMLS:C0007634
28296680	902	931	Ewing sarcoma/peripheral PNET	T038	UMLS:C0684337
28296680	939	944	PNETs	T038	UMLS:C0206663
28296680	974	979	tumor	T038	UMLS:C0027651
28296680	998	1005	ovarian	T017	UMLS:C0205065
28296680	1006	1029	mature cystic teratomas	T038	UMLS:C1368910
28296680	1055	1078	endometrioid carcinomas	T038	UMLS:C0206687
28296680	1086	1108	uterine carcinosarcoma	T038	UMLS:C0280630
28296680	1113	1133	immunohistochemistry	T058	UMLS:C0021044
28296680	1138	1143	PNETs	T038	UMLS:C0206663
28296680	1165	1171	marker	T103	UMLS:C0041366
28296680	1175	1199	neuronal differentiation	T033	UMLS:C1518294
28296680	1211	1224	synaptophysin	T103	UMLS:C0085255
28296680	1226	1229	NSE	T103	UMLS:C1880904
28296680	1231	1235	CD56	T103	UMLS:C0108754
28296680	1237	1241	S100	T103	UMLS:C0027758
28296680	1247	1259	chromogranin	T103	UMLS:C0008586
28296680	1283	1289	tumors	T038	UMLS:C0027651
28296680	1305	1309	GFAP	T103	UMLS:C0017626
28296680	1328	1333	PNETs	T038	UMLS:C0206663
28296680	1370	1380	Membranous	T017	UMLS:C0025255
28296680	1381	1385	CD99	T103	UMLS:C0058889
28296680	1390	1397	nuclear	T082	UMLS:C0521447
28296680	1398	1403	Fli-1	T103	UMLS:C1437505
28296680	1404	1412	staining	T058	UMLS:C0487602
28296680	1435	1441	tumors	T038	UMLS:C0027651
28296680	1472	1482	expression	T038	UMLS:C1171362
28296680	1491	1498	markers	T103	UMLS:C0041366
28296680	1516	1523	central	T038	UMLS:C0206663
28296680	1528	1557	Ewing sarcoma/peripheral PNET	T038	UMLS:C0684337
28296680	1565	1571	tumors	T038	UMLS:C0027651
28296680	1572	1581	expressed	T038	UMLS:C1171362
28296680	1582	1590	vimentin	T103	UMLS:C0042666
28296680	1600	1607	keratin	T103	UMLS:C0022564
28296680	1618	1624	CAM5.2	T103	UMLS:C0910360
28296680	1635	1643	staining	T058	UMLS:C0487602
28296680	1674	1679	PNETs	T038	UMLS:C0206663
28296680	1681	1715	Fluorescence in situ hybridization	T062	UMLS:C0162789
28296680	1758	1763	EWSR1	T017	UMLS:C0808901
28296680	1764	1777	rearrangement	T038	UMLS:C0017287
28296680	1788	1794	tumors	T038	UMLS:C0027651
28296680	1833	1862	Ewing sarcoma/peripheral PNET	T038	UMLS:C0684337
28296680	1878	1882	CD99	T103	UMLS:C0058889
28296680	1887	1892	Fli-1	T103	UMLS:C1437505
28296680	1893	1903	expression	T038	UMLS:C1171362
28296680	1920	1927	central	T038	UMLS:C0206663
28296680	1932	1962	Ewing sarcoma/peripheral PNETs	T038	UMLS:C0684337
28296680	1989	2009	female genital tract	T017	UMLS:C0017421
28296680	2015	2028	central PNETs	T038	UMLS:C0206663
28296680	2048	2061	Central PNETs	T038	UMLS:C0206663
28296680	2121	2124	CNS	T022	UMLS:C3714787
28296680	2125	2131	tumors	T038	UMLS:C0027651
28296680	2141	2146	EWSR1	T017	UMLS:C0808901
28296680	2147	2160	rearrangement	T038	UMLS:C0017287
28296680	2164	2168	GFAP	T103	UMLS:C0017626
28296680	2169	2179	expression	T038	UMLS:C1171362
28296680	2217	2229	central PNET	T038	UMLS:C0206663
28296680	2253	2276	sarcoma/peripheral PNET	T038	UMLS:C0684337
28296680	2278	2308	Ewing sarcoma/peripheral PNETs	T038	UMLS:C0684337
28296680	2338	2341	CNS	T022	UMLS:C3714787
28296680	2342	2348	tumors	T038	UMLS:C0027651